S. Bryant

Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2.

S. Bryant, R. Bjercke, D. Erichsen, 1999, Circulation research.

Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.

V. Koteliansky, S. Bryant, V. Lindner, 1999, Circulation research.

Cytochrome P450 induction in rat hepatocytes assessed by quantitative real-time reverse-transcription polymerase chain reaction and the RNA invasive cleavage assay.

R. Zivin, M. Burczynski, M. McMillian, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

S. Bryant, V. Lindner, L. Couper, 1997, The American journal of pathology.

Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1.

C. Bredenberg, S. Bryant, V. Lindner, 1997, Circulation research.